Solid Biosciences Inc. Capital Expenditures
Solid Biosciences Inc. (SLDB) reported Capital Expenditures of $315.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-06
- Solid Biosciences Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $150.00K, a 60.21% decline year-over-year.
- Solid Biosciences Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $165.00K, a 30.95% increase year-over-year.
- Solid Biosciences Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $565.00K, a 176.96% increase year-over-year.
- Solid Biosciences Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $85.00K, a 466.67% increase year-over-year.
- Solid Biosciences Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $1.15M, a 76.30% increase from fiscal 2024.
- Solid Biosciences Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $654.00K, a 56.83% decline from fiscal 2023.
- Solid Biosciences Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $1.51M, a 49.75% decline from fiscal 2022.
- Solid Biosciences Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $3.02M, a 135.36% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $150.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $315.00K 10-Q · filed 2026-08-06 | $880.00K derived: sum of 3 quarters · filed 2026-08-06 | $965.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $165.00K 10-Q · filed 2026-05-12 | $730.00K derived: sum of 2 quarters · filed 2026-05-12 | $815.00K derived: sum of 3 quarters · filed 2026-05-12 | $1.19M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $565.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $650.00K derived: sum of 2 quarters · filed 2026-03-19 | $1.03M derived: sum of 3 quarters · filed 2026-08-06 | $1.15M 10-K · filed 2026-03-19 |
| 2025-09-30 | $85.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $462.00K derived: sum of 2 quarters · filed 2026-08-06 | $588.00K 10-Q · filed 2025-11-03 | $792.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $377.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $503.00K 10-Q · filed 2026-08-06 | $707.00K derived: sum of 3 quarters · filed 2026-08-06 | $722.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $126.00K 10-Q · filed 2026-05-12 | $330.00K derived: sum of 2 quarters · filed 2026-05-12 | $345.00K derived: sum of 3 quarters · filed 2026-05-12 | $631.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $204.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $219.00K derived: sum of 2 quarters · filed 2026-03-19 | $505.00K derived: sum of 3 quarters · filed 2026-03-19 | $654.00K 10-K · filed 2026-03-19 |
| 2024-09-30 | $15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $301.00K derived: sum of 2 quarters · filed 2025-11-03 | $450.00K 10-Q · filed 2025-11-03 | $540.00K derived: sum of 4 quarters · filed 2025-11-03 |
| 2024-06-30 | $286.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $435.00K 10-Q · filed 2025-08-12 | $525.00K derived: sum of 3 quarters · filed 2025-08-12 | $908.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $149.00K 10-Q · filed 2025-05-15 | $239.00K derived: sum of 2 quarters · filed 2025-05-15 | $622.00K derived: sum of 3 quarters · filed 2025-05-15 | $1.16M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $90.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $473.00K derived: sum of 2 quarters · filed 2025-03-06 | $1.01M derived: sum of 3 quarters · filed 2025-03-06 | $1.51M 10-K · filed 2025-03-06 |
| 2023-09-30 | $383.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $919.00K derived: sum of 2 quarters · filed 2024-11-06 | $1.43M 10-Q · filed 2024-11-06 | $2.28M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $536.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $1.04M 10-Q · filed 2024-08-13 | $1.90M derived: sum of 3 quarters · filed 2024-08-13 | $2.74M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $506.00K 10-Q · filed 2024-05-15 | $1.36M derived: sum of 2 quarters · filed 2024-05-15 | $2.20M derived: sum of 3 quarters · filed 2024-05-15 | $3.34M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $856.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $1.70M derived: sum of 2 quarters · filed 2024-03-13 | $2.83M derived: sum of 3 quarters · filed 2024-03-13 | $3.02M 10-K · filed 2024-03-13 |
| 2022-09-30 | $839.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $1.98M derived: sum of 2 quarters · filed 2023-11-08 | $2.16M 10-Q · filed 2023-11-08 | $2.82M derived: sum of 4 quarters · filed 2024-03-13 |
| 2022-06-30 | $1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.32M 10-Q · filed 2023-08-14 | $1.98M derived: sum of 3 quarters · filed 2024-03-13 | $2.22M derived: sum of 4 quarters · filed 2024-03-13 |
| 2022-03-31 | $184.00K 10-Q · filed 2023-05-11 | $844.00K derived: sum of 2 quarters · filed 2024-03-13 | $1.08M derived: sum of 3 quarters · filed 2024-03-13 | $1.43M derived: sum of 4 quarters · filed 2024-03-13 |
| 2021-12-31 | $660.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $897.00K derived: sum of 2 quarters · filed 2024-03-13 | $1.25M derived: sum of 3 quarters · filed 2024-03-13 | $1.28M 10-K · filed 2024-03-13 |
| 2021-09-30 | $237.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $586.00K derived: sum of 2 quarters · filed 2022-11-10 | $621.00K 10-Q · filed 2022-11-10 | $681.00K derived: sum of 4 quarters · filed 2023-03-23 |
| 2021-06-30 | $349.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $384.00K 10-Q · filed 2022-08-11 | $444.00K derived: sum of 3 quarters · filed 2023-03-23 | $524.00K derived: sum of 4 quarters · filed 2023-03-23 |
| 2021-03-31 | $35.00K 10-Q · filed 2022-04-27 | $95.00K derived: sum of 2 quarters · filed 2023-03-23 | $175.00K derived: sum of 3 quarters · filed 2023-03-23 | $253.00K derived: sum of 4 quarters · filed 2023-03-23 |
| 2020-12-31 | $60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $140.00K derived: sum of 2 quarters · filed 2023-03-23 | $218.00K derived: sum of 3 quarters · filed 2023-03-23 | $899.00K 10-K · filed 2023-03-23 |
| 2020-09-30 | $80.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $158.00K derived: sum of 2 quarters · filed 2021-11-03 | $839.00K 10-Q · filed 2021-11-03 | $1.48M derived: sum of 4 quarters · filed 2022-03-14 |
| 2020-06-30 | $78.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $759.00K 10-Q · filed 2021-08-16 | $1.40M derived: sum of 3 quarters · filed 2022-03-14 | $2.05M derived: sum of 4 quarters · filed 2022-03-14 |
| 2020-03-31 | $681.00K 10-Q · filed 2021-05-14 | $1.33M derived: sum of 2 quarters · filed 2022-03-14 | $1.98M derived: sum of 3 quarters · filed 2022-03-14 | $3.12M derived: sum of 4 quarters · filed 2022-03-14 |
| 2019-12-31 | $645.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $1.29M derived: sum of 2 quarters · filed 2022-03-14 | $2.43M derived: sum of 3 quarters · filed 2022-03-14 | $4.39M 10-K · filed 2022-03-14 |
| 2019-09-30 | $650.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $1.79M derived: sum of 2 quarters · filed 2020-11-05 | $3.74M 10-Q · filed 2020-11-05 | $5.18M derived: sum of 4 quarters · filed 2021-03-15 |
| 2019-06-30 | $1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $3.09M 10-Q · filed 2020-08-06 | $4.53M derived: sum of 3 quarters · filed 2021-03-15 | $6.65M derived: sum of 4 quarters · filed 2021-03-15 |
| 2019-03-31 | $1.95M 10-Q · filed 2020-05-07 | $3.39M derived: sum of 2 quarters · filed 2021-03-15 | $5.51M derived: sum of 3 quarters · filed 2021-03-15 | $8.73M derived: sum of 4 quarters · filed 2021-03-15 |
| 2018-12-31 | $1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $3.56M derived: sum of 2 quarters · filed 2021-03-15 | $6.78M derived: sum of 3 quarters · filed 2021-03-15 | $7.78M 10-K · filed 2021-03-15 |
| 2018-09-30 | $2.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $5.34M derived: sum of 2 quarters · filed 2019-11-12 | $6.34M 10-Q · filed 2019-11-12 | $6.67M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | $3.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $4.22M 10-Q · filed 2019-08-14 | $4.54M derived: sum of 3 quarters · filed 2020-03-12 | $6.21M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | $1.00M 10-Q · filed 2019-05-13 | $1.33M derived: sum of 2 quarters · filed 2020-03-12 | $2.99M derived: sum of 3 quarters · filed 2020-03-12 | $3.03M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | $326.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $1.99M derived: sum of 2 quarters · filed 2020-03-12 | $2.03M derived: sum of 3 quarters · filed 2020-03-12 | $2.28M 10-K · filed 2020-03-12 |
| 2017-09-30 | $1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $1.70M derived: sum of 2 quarters · filed 2018-11-13 | $1.95M 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $39.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $287.00K 10-Q · filed 2018-08-10 | ||
| 2017-03-31 | $248.00K 10-Q · filed 2018-05-10 | |||
| 2016-12-31 | $392.00K 10-K · filed 2019-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |